Adrenaline versus dopamine for children with fluid-refractory septic shock
Official title: Comparison of the Efficacy of Renaline and Dopamine in the Treatment of Fluid Refractory Septic Shock in Children
Run by University of Health Sciences Lahore · NCT07273526 · Data updated 2026-11-12
This trial will see if adrenaline or dopamine works better to stabilize children (1 month–12 years) whose septic shock does not improve after fluid treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 1 Month to 12 Months |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | University of Health Sciences Lahore Academic / other |
| Locations | 1 site (Faisalābad, Punjab Province) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | December 9, 2025 |
| Trial ID | NCT07273526 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 1 month to 12 years with a diagnosis of fluid-refractory septic shock who meet the trial's operational definition and do not meet exclusion criteria are appropriate candidates.
✕Probably not a fit
Children with recent cardiopulmonary bypass, chronic systemic illnesses (like chronic kidney disease, cerebral palsy, or congenital heart disease), neuromuscular or metabolic disorders, or those treated elsewhere without records are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled trial enrolling children with fluid-refractory septic shock who are randomized to receive either adrenaline or dopamine. Treatments are compared by monitoring heart rate, Glasgow Coma Scale, capillary refill time, palpable peripheral pulses, urine output, and systolic blood pressure at predefined time points. The trial is conducted at a single pediatric tertiary center in Faisalabad and follows patients through early hemodynamic response. Children with recent cardiopulmonary bypass, major chronic systemic, neuromuscular, or metabolic disorders, or incomplete prior treatment records are excluded.
Why it matters
Potential benefit: If successful, the trial could identify which vasopressor restores circulation faster and reduces complications in children with fluid-refractory septic shock.
How similar studies have gone: Other pediatric and adult trials have compared epinephrine/adrenaline and dopamine with mixed results, so further randomized pediatric data are needed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients of both Genders having age range between 1month and 12 years with diagnosis of fluid refractory septic shock as per operational definition. \- Exclusion Criteria: * Patients with 1. cardiopumonary Bypass during last 5 days 2. Chronic Systemic disease like Chronic kidney Disease , cerebral palsy, congenital heart disease 3. neuromuscular discorder 4. Metabolic disorders 5. Those who already had treatment at periphery for hypovolemia without any record of medication or sequential organ failure at presentation
Where it's running
-
The Children Hospital and The Institute of Child Health Faisalabad
Faisalābad, Punjab Province, Pakistan Recruiting
Study contacts
- Study coordinator: Hafiz Muhammad Abdullah Dr, MBBS
- Email: mbilal1857@gmail.com
- Phone: 03440846288
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adjunctive Fludrocortisone in Septic Shock on Hydrocortisone
In septic shock, this trial tests whether adding fludrocortisone (50 mcg or 100 mcg daily) to hydrocortisone improves survival and recovery compared with placebo.
-
Non-invasive hemodynamic guidance for sepsis care on medical wards
This trial tests whether guiding fluid and vasopressor therapy for sepsis using non-invasive hemodynamic measurements works better than standard care.
-
Reducing Endotoxin Burden in Septic Shock Patients on CRRT with the oXiris Filter
This trial tests whether using the oXiris hemofilter during continuous kidney replacement helps lower endotoxin levels in adults with septic shock who need CRRT.
-
Personalized Fluid Resuscitation in the Emergency Department
This pilot test checks if a quick, non-invasive stroke-volume assessment can help ED doctors tailor IV fluids for septic patients with low blood pressure.
-
Discordance between capillary refill time and oxygen use in septic shock
This study tests whether some septic shock patients can have a normal capillary refill time but still lack tissue oxygen use, to see if that mismatch relates to 28-day survival.
-
Targeting upper-normal magnesium to see if norepinephrine needs drop in septic shock
This trial tests whether keeping magnesium levels at the upper end of normal can reduce the amount and duration of norepinephrine needed in adults with septic shock.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.